Cingulate EVP granted options for 3,422 shares
Cingulate Inc. reported that EVP and CSO Raul R. Silva received a grant of stock options covering 3,422 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cingulate Inc. reported that EVP and CSO Raul R. Silva received a grant of stock options covering 3,422 shares of common stock. The options have an exercise price of $6.21 per share, were granted at no purchase cost, and expire on March 31, 2036. The award was made pursuant to Dr. Silva's Employment Agreement, as amended, and reflects equity-based compensation rather than an open-market share purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to Buy) | 3,422 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.
Key Figures
Key Terms
Stock Option (right to Buy) financial
Grant, award, or other acquisition financial
underlying security financial
Employment Agreement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cingulate (CING) report for Raul R. Silva?
What is the exercise price of Raul R. Silva’s Cingulate (CING) stock options?
When do Raul R. Silva’s Cingulate (CING) stock options expire?
How were Raul R. Silva’s new Cingulate (CING) options authorized?
AI-generated analysis. How Rhea-AI works. Not financial advice.